Related Experiment Video

Updated: Jul 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

HSPA1B polymorphism in familial forms of inflammatory dilated cardiomyopathy

Irene Portig, Frank Kliebe, Christina Kliebe

    International Journal of Cardiology
    |January 15, 2008
    PubMed

    Insights

    Familial dilated cardiomyopathy (fDCM) may involve immune system pathways, linked to the HSPA1B gene polymorphism. This finding suggests a potential role for autoimmune processes in fDCM development and progression.

    Area of Science:

    • Cardiology
    • Genetics
    • Immunology

    Background:

    • Familial dilated cardiomyopathy (fDCM) pathogenesis involves cytoskeletal gene mutations and inflammatory processes impacting left-ventricular function.
    • An association between inflammatory fDCM and the HSPA1B 1267 A-->G polymorphism has been identified.
    • This polymorphism is also linked to autoimmune disorders, suggesting a potential pathogenetic role for immune phenomena in fDCM.

    Discussion:

    • The HSPA1B 1267 A-->G polymorphism is part of an extended DR3 haplotype, explaining strong allele associations.
    • This genetic link suggests that (auto-)immune mechanisms may contribute to specific forms of familial DCM.
    • Understanding these genetic associations is crucial for classifying susceptibility genes and identifying causative agents.

    Key Insights:

    • Cytoskeletal gene mutations are implicated in fDCM.
    • Inflammatory reactions and the HSPA1B 1267 A-->G polymorphism are associated with fDCM.
    • A potential link between fDCM, autoimmunity, and specific genetic haplotypes is highlighted.

    Outlook:

    • Further research using recombinant haplotype mapping can identify and classify fDCM susceptibility genes.
    • This genetic classification may help pinpoint the unknown causative agents in fDCM.
    • Investigating the role of immune system involvement could lead to novel therapeutic strategies for fDCM.

    More Related Videos

    A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

    A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

    Published on: July 14, 2016

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Genome-wide Association Studies-GWAS01:11

    Genome-wide Association Studies-GWAS

    Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
    GWAS does not require the identification of the target gene involved in...
    Huntington Disease l: Introduction01:21

    Huntington Disease l: Introduction

    Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...